Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (2921)	8/9/1999 8:37:00 PM
From: Kevin Podsiadlik	Respond to of 10293

<< the Y2K hoax >> There is a similar effect that I'm researching right now that I am tenatively calling the "Y1999 effect". It appears to be a bug in the brains of certain Internet stock traders who, on January 1st, failed to register the change in year and as a result think it's still 1998. It's the only explanation I've been able to come up with for certain posts here on SI and elsewhere which continue refer to "Internet valuation" as some exceedingly high level.

To: Bill Wexler who wrote (2921)	8/10/1999 12:32:00 AM
From: BDR	Read Replies (3) \| Respond to of 10293

Bill or anyone else- have you looked at SAFS? I was browsing through the 10-Q and came across some interesting items. --The company readily admits to funding operations through repeated sales of stock. Reg-S in the past. Numerous recent private placements but check the price--- (a) Private Placement Offerings In November 1998, the Company began a new private placement of common stock. During the period from January 1, 1999 through March 31, 1999, the Company sold 1,395,569 shares of common stock at $4.50 per share. The Company had sold 179,222 shares of common stock at $4.50 per share as of December 31, 1998. ---From November through the present time I can only find a few days when the stock sold at or just below $4.50. Very nice deal for the buyer, but the stock option plan is even better--- (b) Stock Option Plan The Company has entered into agreements with various employees and consultants for the grant of stock options and shares of common stock at $0.01 per share. During the three months ended March 31, 1999, the Company granted options and shares totaling 144,615 shares, and recorded charges to operations of $655,206, relating to these grants. The charge to operations represented the fair market value of the underlying common stock or option. As of March 31, 1999, the Company had committed to grant options to purchase 230,000 shares of common stock at $0.01 per share upon the attainment of future milestones. ---I haven't heard of stock options being granted at a price of $.01. That may explain the extensive list of insider sales:http://quicken.excite.com/investments/insider/?symbol=SAFS --- ---Despite a long list of herbicides, fungicides, fertilizers, household cleaning solutions and cancer drugs and despite mentions of marketing links with AOL and large radio audiences the company reports:--- Results of Operations: Three Months Ended March 31, 1999 versus Three Months Ended March 31, 1998 As a development stage enterprise from the date of its inception, the Company has not derived any product sales or net income. ---The recent buzz seems to be from their cancer cure--- Complex Carbohydrate Substance (GBC-590) GBC-590 offers a completely different approach to controlling the progression of cancer, disrupting the essential cellular recognition process of roaming cancer cells and preventing them from reattaching to each other and to normal tissue. IGG scientists designed and developed the GBC-590 compound, which recognizes specific lectins on cancer cells. The substance acts as a molecular decoy by attaching itself to cancer cells and preventing those cells from aggregating. Eliminating the ability of the targeted metastatic cells to create an emboli leaves only individual cancer cells to remain in the blood circulation. GBC-590 may thus prevent or even reverse metastasis. The body's immune system can then destroy the individual cancer cells marked with the carbohydrate molecule. ---Phase I results were successful:--- quicken.excite.com "The results show that the compound is well tolerated at all administered dose levels. These data confirm the excellent safety profile which was first reported in the GBC-590 Phase I trial in prostate cancer at the MD Anderson Cancer Center." ---But Phase one results only have to demonstrate safety to be successful. Efficacy will have to wait for Phases II and III.---

To: Bill Wexler who wrote (2921)	8/10/1999 1:08:00 AM
From: Marconi	Respond to of 10293

Hello Mr. Wexler: y2k and religion I agree with your conclusion--bizarre human trait, otherwise known more accurately as sinful human pride and thinking. Those that claim to know Judgment Day are carrying out bad theology in defiance of Scripture which clearly states no one will know the time; the Father alone knows. This is popular in reformed circles where man's reason has been elected to take precedence over what God says, or simple faith. Such a deed is an act of unbelief. The millenialist factions similarly are looking for an earthly kingdom when Scripture clearly points out the new Israel is the body of all believers from Adam to the end of time, and that this world will continue to deteriorate in sin until if it were possible even the believers would be wrested from their faith. Anyone ascribing to these human ideas in defiance of God's Word is playing the role of a fool. To follow a fool in their foolishness for investment considerations--well, let's say you and I would not consciously plan to do so, and would advise others to avoid doing so, too. This kind of ungodly mystical nonsense is worthless for investments and misleading to those not sure of God's Word. Millenialism and doomsdayers are not orthodox Christianity, but are reflections of departure from faith. These strayers need to be gently reminded of God's truth with love. In my estimation, there are many other issues for software to handle regarding near term dates. So far business continues to adapt. Those businesses that do not adapt may suffer the consequence of having less future choices or next to none at all (out of business)...which is healthy pruning of the less diligent in the long run. Common economics and sense lay the foundation that people will continue to want to carry out economic activities, so the basic drive to adapt will continue. There is no evident trigger for the majority of people to suddenly become mob-like because of the label for another day. Their basic economic predilections will prevail in general. Best regards, m